Navigation Links
Glenn Foundation for Medical Research commits $5 million to study aging
Date:7/10/2008

NEW YORK, July 7, 2008 The Glenn Foundation for Medical Research, founded by philanthropist Paul F. Glenn, has announced a $5 million commitment to the American Federation for Aging Research (AFAR) to provide grants to scientists studying the biology of aging and age-related diseases. This grant provides timely support as current cutbacks in federal funding jeopardize the careers of hundreds of promising investigators who are working to understand how aging influences disease.

The Glenn Foundation funds will go toward the AFAR Research Grant Program and the Glenn/AFAR Breakthroughs in Gerontology (BIG) Awards. AFAR Research Grants provide start-up funding to scientists in the early phases of their careers, enabling them to study the basic mechanisms of aging, age-related diseases and processes underlying common geriatric functional disorders. The Glenn/AFAR Breakthroughs in Gerontology Awards support innovative higher-risk research that may offer significant promise of yielding transforming discoveries in the fundamental biology of aging that could lead to major new insights into the factors that regulate aging.

"As the number of older adults in the United States continues to grow, there is a greater need not only to provide high-quality medical care but also to develop new scientific knowledge about aging processes and age-related diseases and disorders that will allow more people to live healthier longer, free of disability. Aging research is about studying the young, before the body breaks down. Scientists search for clues about why we develop diseases later in life," said Stephanie Lederman, executive director, AFAR. "The forward-thinking vision of Paul Glenn and the Glenn Foundation will allow greater distribution of resources to novel research that will benefit all of us as we age," she added.

"We are proud to support the work of AFAR," said Mark R. Collins, president of the Glenn Foundation for Medical Research. "Longer life brings with it vulnerability to diseases such as Alzheimer's, Parkinson's, osteoporosis, diabetes and others. Funding of aging research is an important path to the alleviation of suffering and reduced healthcare costs. This research forms the backbone of scientific advances in our understanding of aging. AFAR is a key organization in assuring that the best research remains supported."

Nearly 2,500 researchers have been recipients of AFAR-supported grant awards, many of whom have gone on to distinguish themselves as leaders in the field of aging research, chairing departments and running laboratories at major academic institutions. Many of the nation's leaders in biogerontology have been beneficiaries of AFAR grant programs.


'/>"/>

Contact: Stacey Harris
stacey@afar.org
212-703-9977
American Federation for Aging Research
Source:Eurekalert

Related biology news :

1. Balzan Foundation announces 2007 winners
2. Keck Foundation funds study of biological interactions with nanomaterials
3. Yu receives research funding from the Wallace H. Coulter Foundation
4. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
5. Simons Foundation awards Emory scientists $3M for autism gene research
6. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
7. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
10. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
11. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology: